logo
Egypt Prepares First AI-Powered National Platform for Remote Diagnosis

Egypt Prepares First AI-Powered National Platform for Remote Diagnosis

CairoScene13-05-2025

Backed by WHO guidelines, the new platform aims to boost diagnostic speed and accuracy across Egypt's healthcare system.
May 13, 2025
Egypt is preparing the pilot launch of its first national artificial intelligence-based platform for remote medical diagnosis, according to Dr. Ahmed El-Sobky, Chairman of the General Authority for Healthcare and Supervisor of the Comprehensive Health Insurance Project. The new platform will rely on the latest treatment protocols issued by the World Health Organization (WHO), with the goal of improving diagnostic accuracy and reducing response times across public health services.
The announcement came during a meeting between Dr. El-Sobky and Dr. Nima Saeed Abid, WHO Representative in Egypt, as the two parties discussed strategies to advance the country's healthcare system. Dr. El-Sobky noted that the Authority is already a regional leader in adopting global medical standards, having implemented both the ICD-11 disease classification and ICHI intervention coding systems—becoming the first healthcare body in the MENA region to do so.
These systems are expected to significantly improve public health tracking, inform national health policies, and support clinical decision-making at scale. The AI platform is part of a broader digital transformation plan aimed at aligning Egypt's healthcare sector with international best practices.
The collaboration between WHO and the General Authority for Healthcare focuses on six key areas, including joint research, the establishment of a WHO-accredited emergency medical team, and the launch of a Collaboration Centre specialising in clinical governance and infection control. These initiatives are designed to enhance care quality and safety across Egypt's healthcare infrastructure.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Health Ministry Eliminates Medical Paper Records
Health Ministry Eliminates Medical Paper Records

CairoScene

time14 hours ago

  • CairoScene

Health Ministry Eliminates Medical Paper Records

The announcement was made at a ceremony recognising Egypt as the first in the region to meet WHO's hepatitis B control target. Jun 04, 2025 The Ministry of Health and Population has announced the complete elimination of paper records across all health offices, marking a step in Egypt's healthcare digital transformation. Deputy Minister Dr. Amr Qandil confirmed that a unified digital system has been rolled out across health and vaccination offices nationwide, in order to improve service delivery and administrative efficiency. As part of the new system, parents receive automated SMS reminders 48 hours before scheduled vaccination appointments. The ministry currently operates around 5,300 vaccination points across the country, administering approximately 65 million doses annually. These include vaccinations for newborns, schoolchildren, healthcare workers, high-risk groups such as dialysis patients, and refugees. The announcement was made during a ceremony celebrating Egypt's achievement in hepatitis B control, where the country was recognised as the first in the Eastern Mediterranean region to meet the World Health Organization's target of reducing prevalence below 1% among children aged five and older. This digital shift is part of the broader national strategy to integrate technology into public health infrastructure and expand access to comprehensive healthcare services.

Egypt Becomes First in Region to Meet WHO Target on Hepatitis B
Egypt Becomes First in Region to Meet WHO Target on Hepatitis B

CairoScene

time14 hours ago

  • CairoScene

Egypt Becomes First in Region to Meet WHO Target on Hepatitis B

Egypt is the first Eastern Mediterranean country to reduce hepatitis B prevalence below 1% among children aged five and older. Jun 04, 2025 Egypt has officially become the first country in the Eastern Mediterranean region to meet the World Health Organization's target for controlling hepatitis B, according to a recent review by the WHO Regional Committee. The milestone confirms that hepatitis B prevalence among children aged five and above in Egypt has dropped below 1%, meeting the benchmark for regional control. This achievement follows years of consistent immunisation efforts. National vaccination coverage has remained above 90% for both the hepatitis B birth dose and the third dose for over a decade—one of the highest sustained rates in the region.

Egypt's pharmaceutical market hits EGP 309bn in 2024, marking 43% growth
Egypt's pharmaceutical market hits EGP 309bn in 2024, marking 43% growth

Daily News Egypt

timea day ago

  • Daily News Egypt

Egypt's pharmaceutical market hits EGP 309bn in 2024, marking 43% growth

Egypt's pharmaceutical market recorded EGP 309bn in sales in 2024, up from EGP 216bn in 2023—reflecting a 43% year-on-year increase, according to Ali Ghamrawy, Chairperson of the Egyptian Drug Authority (EDA). The announcement came during the EDA's 15th Board of Directors meeting, attended by Deputy Prime Minister for Human Development and Minister of Health and Population Khaled Abdel Ghaffar, Deputy Prime Minister for Industrial Development and Minister of Industry and Transport Kamel El-Wazir, Minister of Investment and Foreign Trade Hassan Mohamed El-Khatib, and Presidential Health Advisor Mohamed Awad Tag El-Din, alongside other senior officials. The meeting reviewed several strategic updates, including the latest activities of the Permanent Committee of the Egyptian Pharmacopeia and progress in digital transformation across the Authority. These digital initiatives aim to enhance service delivery efficiency and strengthen the institutional work environment. A key highlight of the meeting was the EDA's continued success in gaining international accreditation. In December 2024, the World Health Organization (WHO) awarded the Authority Maturity Level 3 status in the field of medicines—an achievement that follows its earlier Maturity Level 3 accreditation for vaccines in March 2022. EDA laboratories have also been accredited by both the WHO and the European Union, a milestone that positions them as globally recognized reference labs. The Authority's growing international presence was further underscored by its contributions to regulatory capacity-building programs across the Arab and African regions. With WHO Maturity Level 3 recognition in both medicine and vaccine regulation, the EDA has assumed a leading role in supporting regulatory system development throughout Africa. The African Union Development Agency – NEPAD (AUDA-NEPAD) has selected EDA's Continuing Professional Development Center as a Regional Centre of Regulatory Excellence (RCORE). Under this designation, the Authority has conducted 12 international training programs for countries including Libya, Yemen, Ghana, and Algeria. Additionally, the meeting showcased progress in EDA's internship programs, including the pilot launch of a new Learning Management System (LMS) platform aimed at enhancing professional training and knowledge transfer.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store